In digital communication, the principle of "proximity creates responsibility" is truer than ever. Healthcare companies also benefit enormously from channels like Instagram, WhatsApp, and Facebook, but they must also face regulatory realities. As soon as users post publicly, the company becomes (partly) responsible, at least in certain areas.

Whether it's a personal account, a recommendation, or even a medication name – what seems authentic and harmless can become legally problematic. This is especially true in the context of the German Act on Advertising of Therapeutic Products (HWG).) and internal communication guidelines.

Many users describe their personal medical histories online – often combined with promotional and comparative statements.

However, depending on the context, such statements may violate Section 11 of the German Advertising Act (HWG) or general competition law provisions – especially if:

• Specific products will be mentioned.
• Disease progression or treatment successes are described.
• Acknowledgements or recommendations are given

Even if the content originates from a third party, companies are obligated to moderate or remove it as soon as they become aware of it. Furthermore, companies must ensure they can regularly access such content. Otherwise, the statement could be attributed to them.

And this is exactly where evalii® comes into play: as a tool for all digital communication.

evalii® is far more than a pharmacovigilance monitoring system: Incoming content can not only be checked for potential adverse event reports, but also for:

• HWG-critical statements
• Violations of netiquette guidelines
• problematic comment types such as misinformation or sensitive content

As soon as relevant content is detected, a report is also issued here following a coordinated process:

• Either through our team: We review, evaluate and act according to your specifications.
• Or through your internal department/agency: evalii® immediately sends an email notification to the responsible person.

This way you can decide individually who moderates, but you won't miss any comments.

Why this matters to you:

• Greater security in the digital space – even with high interaction and high volume of comments

• Early warning system for potential violations of the German Medicines Advertising Act (HWG) – Risks become immediately visible
• Proactive moderation reduces legal risks and protects against escalations or shitstorms
• Audit-proof documentation of all incidents – traceable and verifiable at any time
• Seamless integration into existing SOPs, role models and internal processes – evalii® adapts to your organization

 

While other tools stop at PV notifications, evalii® ensures comprehensive communication security – from social media to messengers to web forms.

Your users are allowed to communicate. And you retain control.

Image: © Adobe Stock / 1518317541

Der Beitrag Mehr als Pharmakovigilanz: Wie evalii® auch Netiquette und HWG-Konformität sichert erschien zuerst auf evalii - pharmacovigilance monitoring service.

Social Media has become a central communication channel for many pharmaceutical companies. Whether it's a Facebook page, Instagram campaign, or YouTube channel – information about medications, services, and indications is increasingly shared via social networks.

It is often underestimated that with increasing visibility on social media comes increasing regulatory responsibility.
Pharmacovigilance on social media is not an option, but a legal requirement.

This duty to monitor also extends to Social media platforms like Facebook, Instagram, X (formerly Twitter) or YouTube.

However, companies are not responsible for third-party content, but for all channels on which you are active or have influence.
This means that all posts, comments, reactions, and direct messages on the company's own profiles or profiles equivalent to these must be regularly checked for possible indications of adverse drug reactions (AEs).

Social media differs significantly from traditional communication channels – especially with regard to Pharmacovigilance:

Real-time communication around the clock
Comments can appear at any time—even at night or on weekends. A sporadic review isn't enough; continuous monitoring is required.

High interaction density
A single post on Facebook or Instagram can trigger hundreds of comments. Personal experiences are common, especially when it comes to health or product questions – and potentially relevant to PV.

Different formats and channels
On Instagram, people often respond via stories, on YouTube via the comment function, and on Facebook via Messenger. An effective solution must take all of these formats into account.

Public visibility
Statements on social media are often visible to everyone. Overlooking indications of side effects can have not only regulatory but also reputational consequences.

evalii® is a specialized solution to Implementing pharmacovigilance requirements on social media in an automated and legally compliant manner – around the clock, on all relevant platforms.

What evalii® offers:

Automated monitoring of your own social media channels
Whether Facebook, Instagram, X or YouTube, evalii® systematically and continuously scans comments, messages and posts on company profiles.

Recognition of PV-relevant statements
Side effects are identified, classified and marked, even in indirect or colloquial formulations.

Documentation & Compliance
Every find is documented, including timestamp, channel, text excerpt, and processing status – fully auditable and GDPR compliant.

Integration into existing processes
evalii® can be adapted to individual SOPs, role models and approval processes.

Conclusion: Anyone who communicates on social media must also ensure pharmacovigilance

Pharmacovigilance on social media is not just a regulatory obligation – it is a patient safety imperative.
As social media presence grows, so does responsibility. Companies that actively use Facebook, Instagram or other platforms must also Check for PV-relevant content around the clock.

evalii® makes this task not only feasible but also efficient. Social media becomes a channel that is not only informative but also secure.

 

Do you have any questions about evalii® or feasibility? Please contact us: https://www.cross4channel.de/kontakt/

Interested? Feel free to contact us here – or by WhatsApp:

Der Beitrag Pharmakovigilanz auf Social Media: Pflicht, Herausforderung und digitale Lösung mit evalii® erschien zuerst auf evalii - pharmacovigilance monitoring service.

TikTok has rapidly developed into one of the most important platforms for short videos in recent years. With over 1 billion monthly active users worldwide, the app is particularly popular with younger target groups. In Germany, TikTok enjoys a steadily growing user base, with around 20 million users who are active on the platform every day【1】. This popularity makes TikTok an important channel for social interactions, entertainment and, increasingly, for sharing health and medication experiences.

Unlike Facebook or Instagram, TikTok is based almost entirely on video content. This creates a dynamic environment in which trends and challenges play a major role. Especially for companies in the healthcare sector, including the pharmaceutical industry, TikTok opens up new opportunities for patient communication, but also challenges in the area of pharmacovigilance (PV).

Interaction possibilities and pharmacovigilance

There are various interaction options on TikTok that are relevant for pharmacovigilance:

Videos and comments:

The core function of TikTok is short videos uploaded by users. These videos can be commented on and liked by other users. The comments are of particular interest to pharmacovigilance, as users can report on their experiences with medications or treatment methods. These comments must be regularly monitored to identify and report potential adverse drug reactions (ADRs).

The challenge on TikTok is that content can quickly go viral, and therefore continuous monitoring is necessary. Comments on viral videos shared by medical influencers or pharmaceutical companies can contain valuable clues about ADRs. However, identifying such comments requires advanced technologies and a systematic approach.

TikTok Stories:

TikTok also offers the function of posting "stories" that disappear after 24 hours, similar to Instagram and Facebook. Users can react to these stories by liking them as well as commenting. These comments are particularly relevant in the context of pharmacovigilance, as users could share their experiences with medications there. Since stories are only available temporarily, they need to be monitored in real time to ensure that potentially important information is not lost.

Private messages (direct messages, DMs):

Like other platforms, TikTok allows direct messaging between users. This feature is often used for private conversations, but it can also be used to exchange information relevant to pharmacovigilance. Since these messages can contain confidential information, it is important to strictly adhere to data protection policies and have a reliable system for monitoring and documenting such messages.

Stitch and Duet videos:

TikTok offers unique interaction opportunities through "Stitch" and "Duet" functions. Users can react to existing videos or edit them and add their own content. When a user reports on their experience with a drug and other users respond with their own experiences, potentially relevant information for PV can emerge. Monitoring such content is particularly challenging because it is often shared in different formats and across multiple videos.

Special features of the TikTok platform for PV monitoring

Unlike Facebook and Instagram, TikTok does not currently offer a public API that allows for easy monitoring of content. This means that manual monitoring on TikTok can be particularly time-consuming and error-prone. The platform is also heavily influenced by rapid changes and new features, making it difficult to establish a consistent monitoring process.

Another aspect is the speed at which content can go viral on TikTok. A single video can reach millions of views in a matter of hours, making continuous, automated monitoring essential.

Monitoring with evalii®

TikTok is a platform that particularly appeals to younger users, but is also becoming increasingly relevant for health and medical devices. By systematically monitoring videos, comments and private messages, potential PV events can be identified and reported at an early stage, as required by legal requirements.

evalii® offers you the possibility to efficiently monitor your TikTok projects and campaigns and ensure that no relevant information is overlooked. With evalii® you can take advantage of modern technologies to optimize your patient communication and ensure the safety of your products.

Sources:

【1】 Statista: Number of TikTok users in Germany

Cover image © Adobe Stock | tashatuvango

Der Beitrag TikTok & Pharmakovigilanzmonitoring erschien zuerst auf evalii - pharmacovigilance monitoring service.

Facebook is one of the largest social platforms in the world and plays a central role in digital communication. With over 2.8 billion monthly active users worldwide, Facebook is a platform that connects people, exchanges opinions and shares information. In Germany, around 32 million people are active on Facebook, making the platform an important channel for social interactions and information exchange. 【1】

Recently, the use of Facebook in Germany has changed. While the number of younger users has decreased, the number of older users is steadily growing. This is because Facebook not only serves as a social network, but also as a source of news and a means of communication for different age groups.

Facebook's functions have also evolved to meet the needs of users. New features such as Facebook Stories, Marketplace and Groups have helped to keep the platform attractive. The demographic development, which could reduce the relevance of Facebook in Germany in the long term, makes the platform particularly relevant for the moment for any medical indications that affect patients aged 40+.

Interaction options and their relevance for pharmacovigilance

Facebook offers a variety of opportunities for interaction that make appropriate pharmacovigilance monitoring essential. These include comments, guest posts and private messages that may contain potentially reportable events.

Comments:

Comments are one of the most common forms of interaction on Facebook. Users can comment on posts by companies, organizations or other users. Comments on posts by a pharmaceutical company are of particular interest to pharmacovigilance, as users often share personal experiences with medications. Such comments can provide evidence of adverse drug reactions (ADRs). It is important that these comments are regularly monitored to identify and report potential PV events. A systematic approach to monitoring and analyzing comments can not only help to identify potential safety issues at an early stage, but also reveal valuable information about your target audience.

Guest contributions:

Guest posts, also known as user-generated content (UGC), are posts posted by users on company pages or in groups. While most companies do not allow or disable guest posts, these posts, if not blocked, can contain detailed accounts of personal experiences with medications. Guest posts often provide more detailed information than comments and can provide specific data on ADRs and their circumstances. Systematic monitoring and evaluation of these posts is essential for regulatory compliance and can provide important insights into the safety and effectiveness of medications.

Private messages:

Private messages provide a direct and personal means of communication between users and companies. While many users use this feature for personal conversations, information about ADRs can also be shared here. It is necessary for companies to have an effective system for monitoring and documenting such messages to ensure that no relevant information is missed. Since private messages can contain sensitive information, it is important to strictly adhere to data protection policies and protect user privacy.

Special features of the Facebook platform for PV monitoring

While META provides an interface for retrieving comments, it can by no means be described as reliable. Changes to the interface, which META makes frequently and irregularly, must always be kept in mind in order to enable the retrieval of comments reliably.

There are also a number of interaction options on Facebook pages, such as the so-called page ratings, which are rarely used but still allow free text. Due to the complexity of the platform, which has grown over a long period of time, changes or additions to these interaction options can easily be overlooked, so it is crucial for pharmacovigilance monitoring to keep a close eye on them.

Monitoring with evalii

In summary, Facebook is still an important platform in Germany today. Through systematic monitoring of comments, guest posts and private messages, potential PV events can be identified and reported at an early stage, as required by law.

evalii offers you the opportunity to efficiently monitor your Facebook projects & campaigns and ensure that no relevant information is overlooked. With evalii you can take advantage of modern technologies to optimize your patient communication and ensure the safety of your products.

Sources:

【1】 [Statista: Number of Facebook users in Germany](https://de.statista.com/statistik/daten/studie/221041/umfrage/anzahl-der-facebook-nutzer-in-deutschland/)

Der Beitrag Facebook & Pharmakovigilanzmonitoring erschien zuerst auf evalii - pharmacovigilance monitoring service.

Instagram has established itself as one of the fastest-growing social platforms worldwide, with a focus on visual content. The platform allows users to share photos and videos, post stories and communicate via direct messages. With over 1 billion monthly active users worldwide, including around 21 million in Germany, Instagram is an important channel for personal and commercial exchange 【1】.

In recent years, Instagram has evolved from a platform for lifestyle and leisure photos to an important tool for brand communication and customer interaction. Companies are increasingly using Instagram to reach their target audiences with engaging visual content, and this is also true for the pharmaceutical industry.

In Germany, Instagram has steadily grown in popularity in recent years, especially among younger users. Companies are increasingly recognizing the platform's potential for marketing and customer communication. The introduction of features such as IGTV, Reels and shoppable posts has expanded the opportunities for interaction and engagement. For pharmacovigilance (PV), Instagram offers unique challenges and opportunities, as users often share their health and medication experiences in images and videos.

Interaction possibilities and pharmacovigilance

Monitoring Instagram in the context of pharmacovigilance requires a deep understanding of the platform and its different forms of interaction:

Posts and comments:

The most popular format on Instagram is regular posts. These photos and videos can be commented on by users at any time, both immediately after they are published and weeks or months later. This fact makes it crucial to establish a reliable process for monitoring profiles that publish new posts weekly, for example. In reality, a strictly manual process is often not efficiently feasible, so when operating your own profiles you should always rely on an automated solution to identify new comments.

Stories and Reels:

Instagram Stories and Reels are short, temporary videos that often complement posts. Like the posts themselves, Stories and Reels can be commented on. Users often share everyday moments here, including their experiences with medication. This content disappears after 24 hours (Stories) or remains permanently on the profile (Reels), which requires continuous monitoring.

Direct messages:

Direct messages on Instagram allow private communication between users and companies. Here, users can share detailed and personal stories about their experiences with medication. It is important to have an effective system for monitoring and documenting these messages so that no relevant information is missed. Data protection and confidentiality must always be guaranteed.

Influencer marketing:

Another important aspect on Instagram is influencer marketing. Influencers who promote medicines or health products can have a large reach and exert considerable influence on their followers. Posts and stories from influencers who report on their experiences with medicines can also contain relevant information for pharmacovigilance. Monitoring this content is particularly important when working with an influencer to ensure that all legal requirements are met and potential ADRs are reported.

Special features of the Instagram platform for PV monitoring

While META provides an interface for retrieving comments, it can by no means be described as reliable. Changes to the interface, which META makes frequently and irregularly, must always be kept in mind in order to enable the retrieval of comments reliably.

Furthermore, Instagram accounts can only be monitored if there is an existing technical connection to a Facebook page via the API (interface).

Monitoring with evalii

Instagram is probably the most important social media platform for a variety of medical indications and thus the pharmaceutical industry, as it attracts a large number of regularly active users and visual content that can contain valuable information. By systematically monitoring posts, comments, stories, reels and direct messages, potential PV events can be identified and reported at an early stage, as required by legal requirements.

evalii offers you the possibility to efficiently monitor your Instagram projects & campaigns and ensure that no relevant information is overlooked. With evalii you can take advantage of modern technologies to optimize your patient communication and ensure the safety of your products.

Sources:

【1】 [Statista: Number of Instagram users in Germany](https://de.statista.com/statistik/daten/studie/221041/umfrage/anzahl-der-instagram-nutzer-in-deutschland/)

Der Beitrag Instagram & Pharmakovigilanzmonitoring erschien zuerst auf evalii - pharmacovigilance monitoring service.

LinkedIn has established itself as the world's leading professional networking platform, specifically geared towards the needs of professionals and companies. With over 800 million members worldwide, LinkedIn offers a unique opportunity for professional networking, career development and knowledge sharing. In Germany, around 18 million people use LinkedIn, making the platform an important channel for professional interactions and the exchange of expertise. 【1】

Over the last three years, LinkedIn has grown significantly in importance in Germany. More and more professionals and companies are using the platform to network, follow industry news and discover business opportunities. LinkedIn has developed from a simple network for professional contacts into a comprehensive platform that is also used as a news source and for the exchange of specialist articles and opinions. This makes LinkedIn particularly attractive for the field of pharmacovigilance, as it has a high proportion of professionals who share well-founded discussions and reports.

Interaction possibilities and pharmacovigilance

Even though LinkedIn is not technically operated directly by the pharmaceutical industry, the good pharmacovigilance practices (GVP) The EU requires monitoring of digital media if they are financed by a pharmaceutical company or are under its responsibility.

Since the interaction options on LinkedIn are diverse and offer numerous approaches for pharmacovigilance monitoring, it is important to look at the structure of the platform in detail. Particularly noteworthy are:

Articles and contributions:

LinkedIn users regularly publish scientific articles and posts that may contain detailed information and personal experiences. These posts are particularly valuable for pharmacovigilance as they can provide specific data on adverse drug reactions (ADRs) and their circumstances. Monitoring such content can provide important insights into the safety and effectiveness of medications.

Comments:

Comments on posts and articles often provide in-depth insights and expert opinions. Users who leave comments are often experts or affected parties who can share relevant information about ADRs. A systematic approach to monitoring and analyzing comments is crucial to identify and report potential ADR events at an early stage and to ensure that your own LinkedIn pages operate in compliance with the rules.

Groups:

LinkedIn groups that focus on specific specialist areas are another important element for the pharmaceutical industry and pharmacovigilance. These groups provide a platform for the exchange of knowledge and experiences among professionals. Posts and discussions in such groups may contain references to ADRs and must therefore be carefully monitored. In fact, with an appropriately adapted setup, these groups represent an option for the pharmaceutical industry to communicate branded content or information that falls under the Medicines Advertising Act.

Direct messages:

Direct messages allow direct communication between professionals and companies. Although these are often used for professional networking and conversations, they can also contain relevant information about ADRs. Companies must ensure they have an effective system for monitoring and documenting such messages to avoid missing important information.

Special features of the LinkedIn platform for PV monitoring

LinkedIn provides a very reliable interface for retrieving comments on LinkedIn pages, advertising accounts and focus pages.

However, this API does not cover the entire scope of the platform. For example, comments within groups cannot currently be accessed via the API. Therefore, in this case it is crucial to establish an alternative process for monitoring.

Due to the rapid growth of the platform and the associated technological developments, new features and formats are regularly available to LinkedIn users. Only by closely monitoring these additions can it be ensured that no gaps arise in PV monitoring.

Monitoring with evalii®

LinkedIn is a significant platform for pharmacovigilance as it attracts a wide range of professionals and experts who share valuable information. Systematic monitoring of peer-reviewed articles, comments, groups and direct messages allows for early detection and reporting of potential PV events as required by regulatory requirements.

evalii® offers you the opportunity to efficiently monitor your LinkedIn projects & campaigns and ensure that no relevant information is overlooked. With evalii® you can take advantage of modern technologies to optimize your professional communication and ensure the security of your products.

Source: 【1】 [Statista: Number of LinkedIn users in Germany](https://de.statista.com/statistik/daten/studie/221041/umfrage/anzahl-der-linkedin-nutzer-in-deutschland/)

Der Beitrag LinkedIn & Pharmakovigilanz Monitoring erschien zuerst auf evalii - pharmacovigilance monitoring service.

Trend analysis through social networks

Integrating social media into the marketing strategy allows pharmaceutical companies to establish themselves as leading players in the healthcare sector. These online platforms allow them to indirectly engage with patients and also healthcare professionals, which can improve overall information dissemination and patient support. 

By continuously monitoring social networks, valuable insights into the preferences and needs of patients can be gained. This data enables pharmaceutical companies to identify trends and adapt their communication strategies accordingly. Whether it is about educating people about the disease, providing support or assistance, structured social media management can help to identify relevant topics that interest the target group. patient currently moving. 

Community Management – targeted moderation 

Effective community management is crucial to building and maintaining a positive online presence. A trained community manager plays a central role here by not only monitoring communication but also actively moderating it. By setting moderation guidelines that are adapted to the specific needs and regulations of each pharmaceutical company, they ensure that interactions within the community are professional and in line with all legal requirements. 

Regular moderation ensures that inappropriate or misleading content such as spam or shitstorms are quickly identified and addressed, ensuring the integrity of the platform and patient trust. This is especially important in such a sensitive area as healthcare communication, where accuracy and reliability are paramount. 

Pharmacovigilance: An important aspect of social media strategy

With their potential for interaction, social media have also become a critical channel for pharmacovigilance, i.e. drug safety.  
Through ongoing communication between patients about the disease and therapy, potential safety concerns become an issue. Only by monitoring comments and posts can possible side effects be identified and appropriate measures taken.  
Transparent handling of safety concerns strengthens patient trust in pharmaceutical brands. When companies openly and proactively address concerns raised via social media, they not only ensure compliance with international pharmacovigilance regulations, but also lay the foundation for stronger patient engagement and trust. 

evalii® – the solution for efficient PV monitoring

By continuously monitoring and analyzing patient discussions and feedback on social media, evalii® can help to collect and document safety data efficiently and comprehensively – around the clock. 

Our specially trained team, consisting of specialists in medicine, pharmacy, veterinary sciences, biochemistry and other relevant fields, uses the evalii® system to quickly and economically validate the pre-processed data. If necessary, they immediately initiate the necessary steps to comply with pharmacovigilance reporting obligations. 

Benefits for marketing and pharmacovigilance 

For marketing teams, evalii® offers a cost-effective way to optimize patient support, identify trends and adapt communication campaigns. At the same time, the service supports pharmacovigilance teams in fulfilling legal obligations in a time-efficient manner and ensuring patient safety.  

evalii® enables marketing and PV teams to work hand in hand to develop an integrated strategy that both maximizes engagement and ensures patient safety. This synergy not only improves the efficiency of internal processes, but also ensures that every patient interaction contributes to expanding the comprehensive understanding of a drug's safety profile. 

Bottom line 

Social media and communication with patients are essential components of a patient-centered pharmaceutical company. These platforms not only offer the opportunity to deliver tailored health information and promote patient engagement, but also to ensure patient safety through effective monitoring. Pharmacovigilance should not be seen as an obstacle, but as a key advantage that enables faster and more precise responses to patient needs while meeting regulatory requirements. By strategically using tools such as evalii®, pharmaceutical companies can ensure that their social media strategies both strengthen patient engagement and optimize the monitoring and reporting of adverse reactions (pharmacovigilance-requiring events) to protect and promote patient well-being. 

Der Beitrag Social Media und Patientenkommunikation: Unverzichtbar für die Patientenzentrierung der Pharmaunternehmen  erschien zuerst auf evalii - pharmacovigilance monitoring service.

Specialized expertise in action

The role of humans within the evalii® system is crucial for the precision and reliability of our monitoring. Our team consists of professionals with specialized knowledge in medicine, pharmacy, veterinary science, biochemistry and other relevant areas. These experts use the evalii® system to quickly and economically validate the pre-processed data. If necessary, they immediately initiate the necessary steps to comply with pharmacovigilance reporting obligations. 

In addition to pharmacovigilance-specific monitoring, we employ professional social media managers who not only take on online moderation but also carry out editorial tasks. This combination of in-depth technical expertise and state-of-the-art technology enables evalii® to ensure comprehensive and precise monitoring of social media and other digital communication channels. This strengthens our customers' confidence in reliable monitoring that both complies with regulatory requirements and ensures the protection and safety of users. 

Data protection compliance in data analysis 

evalii® ensures that the processing of communication data is carried out in accordance with the strict data protection regulations of the GDPR and the European data protection guidelines by using "blinding" of relevant data. Our advanced technologies, including the anonymization of personal information before analysis, guarantee that the privacy of users is protected, while at the same time valuable insights can be gained from the data. 

Through these procedures, evalii® enables its customers to process data in compliance with all legal requirements. We also offer services that include the use of artificial intelligence and other advanced analysis techniques. These tools allow essential information about patient interests, product use and competitive situations to be extracted despite the high data protection standards. 

This privacy-friendly approach allows our customers not only to comply with legal requirements, but also to use the data to optimize their products and services, which would not be possible without evalii®. 

Economic and legal benefits of monitoring

The implementation of evalii® in the CED Forum illustrates how social media monitoring can not only be made practical and economically sustainable, but also consistently meets regulatory and legal requirements. evalii® combines automated data collection and analysis with human monitoring, reducing the need for constant personnel deployment and thus significantly reducing costs. Our customers benefit from a comprehensive monitoring solution that is not only cost-effective and reliable, but is also well moderated at all times. 

In addition to complying with all regulatory requirements of pharmacovigilance, evalii® also ensures compliance with the German Medicines Advertising Act (HWG) and other legal provisions. This ensures that communication within the community is not only actively managed, but also always complies with the legal framework, which offers additional legal certainty for our customers. 

evalii® in action: How adaptive social media monitoring prevents crises

evalii® adapts flexibly to the specific requirements of each customer and works according to the established guidelines and directives. In addition, thanks to the early detection of trends and moods in communication, our system enables potential crises such as shitstorms or spam to be effectively identified and proactively prevented.  

The combination of technology and human expertise makes evalii® an indispensable tool in social media monitoring, which not only ensures compliance and data protection, but also helps to build a safe and engaged online community. 

Der Beitrag Social Media Monitoring in der Patientenkommunikation am Beispiel des CED Forums erschien zuerst auf evalii - pharmacovigilance monitoring service.